术前竖脊肌肌肉量对I期非小细胞肺癌的影响
本研究回顾性分析534例接受肺叶或肺段切除术的I期非小细胞肺癌患者,通过术前CT评估竖脊肌肌肉量并按身高和性别标准化。肌肉量低者总生存(5年79.6% vs 89.5%,P<0.001)和非肺癌相关死亡(5年累积死亡率14.7% vs 6.8%,P<0.001)显著更差,但肺癌相关死亡无差异。结论认为术前竖脊肌肌肉量与I期非小细胞肺癌预后显著相关。
要点
- 术前竖脊肌肌肉量低者5年总生存79.6%,显著低于肌肉量高者的89.5%(P<0.001)。
- 肌肉量低者5年非肺癌相关死亡累积死亡率14.7%,显著高于肌肉量高者的6.8%(P<0.001)。
- 两组肺癌相关死亡无显著差异。
核心结论
- 术前竖脊肌肌肉量与I期非小细胞肺癌的非肺癌相关死亡强烈相关,是该期患者的显著预后因素。
- 肌肉量低的患者应基于恰当的风险评估进行治疗。
研究设计与样本
- 回顾性分析534例接受肺叶或肺段切除术的I期非小细胞肺癌患者的病历资料。
- 术前通过胸部CT识别竖脊肌,并按身高和性别对肌肉量进行标准化。
- 采用对数秩检验和Gray检验分析总生存、肺癌相关死亡和非肺癌相关死亡,并行多因素分析确定影响总生存和非肺癌相关死亡的因素。
主要发现
- 按身高和性别标准化的竖脊肌肌肉量与年龄和体重指数显著相关。
- 肌肉量低者5年总生存为79.6%,肌肉量高者为89.5%(P<0.001)。
- 肌肉量低者5年非肺癌相关死亡累积死亡率为14.7%,肌肉量高者为6.8%(P<0.001)。
- 肺癌相关死亡在两组间无差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Erector spinae muscle (ESM) is an antigravity muscle group that can be evaluated as an index of muscle loss on chest computed tomography. The amount of ESM has been reported to be related to the prognosis of several respiratory diseases. However, few studies clarify the impact on postoperative non-small-cell lung cancer (NSCLC). We investigated the relationship between ESM and postoperative prognosis in patients with early-stage NSCLC. METHODS: We reviewed the medical records of 534 patients with stage I NSCLC who underwent lobectomy or segmentectomy. The ESM was identified by preoperative computed tomography, and the amount was normalized according to height and sex. Overall survival, lung cancer-related deaths and non-lung cancer-related deaths (NLCRD) were analysed using log-rank and Gray's tests. Multivariable analyses were conducted to identify factors that influenced overall survival (OS) and NLCRD. RESULTS: The amount of ESM normalized according to height and sex was significantly associated with age and body mass index. When the amount was low, OS (5-year OS, 79.6 vs 89.5%; P< 0.001) and NLCRD (5-year cumulative mortality rate, 14.7 vs 6.8%; P< 0.001) were significantly worse, although no difference was found in lung cancer-related deaths. CONCLUSIONS: The amount of preoperative ESM was strongly related to non-lung cancer-related death and was a significant prognostic factor for stage I NSCLC. Patients with a low amount of the muscle should be treated based on proper risk assessment.
引用
- Ueda D, Tsutani Y, Kamigaichi A, et al. Impact of the amount of preoperative erector spinae muscle in stage I non-small-cell lung cancer. Eur J Cardiothorac Surg. 2022. PMID: 36315076. doi:10.1093/ejcts/ezac510
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。